Paraphrase:
In its 2020 report Heritable Human Genome Editing, the commission observed that no country has yet decided that it would be appropriate to move forward with clinical applications of heritable human genome editing.5 The commission described the societal and ethical issues that would need to be debated before arriving at such a conclusion, but it did not make a judgment about whether a safe and efficacious methodology of heritable human genome editing should be permitted. Instead, it laid out a rigorous set of preclinical and clinical criteria that would need to be met before any such procedure could be deemed safe and effective.
1 answer
In its 2020 report on Heritable Human Genome Editing, the commission noted that no country has approved the use of heritable human genome editing for clinical purposes. The report outlined the societal and ethical considerations that would need to be discussed before making a decision, but did not take a stance on whether the practice should be allowed. Instead, the commission proposed a set of strict preclinical and clinical criteria that would need to be fulfilled before considering heritable human genome editing as safe and effective.
1 answer